BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27036064)

  • 1. Genome defense against exogenous nucleic acids in eukaryotes by non-coding DNA occurs through CRISPR-like mechanisms in the cytosol and the bodyguard protection in the nucleus.
    Qiu GH
    Mutat Res Rev Mutat Res; 2016; 767():31-41. PubMed ID: 27036064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paired CRISPR screening libraries for studying the function of the non-coding genome at scale.
    Nat Biomed Eng; 2024 May; ():. PubMed ID: 38822173
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutation detection in the non-coding genome.
    Schuelke M
    Med Genet; 2021 Jun; 33(2):119-120. PubMed ID: 38836025
    [No Abstract]   [Full Text] [Related]  

  • 4. CRISPR-mediated control of the bacterial initiation of replication.
    Wiktor J; Lesterlin C; Sherratt DJ; Dekker C
    Nucleic Acids Res; 2016 May; 44(8):3801-10. PubMed ID: 27036863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of Cas9 cleavage in the chromosome of Escherichia coli.
    Cui L; Bikard D
    Nucleic Acids Res; 2016 May; 44(9):4243-51. PubMed ID: 27060147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step homozygosity in precise gene editing by an improved CRISPR/Cas9 system.
    Zhao P; Zhang Z; Lv X; Zhao X; Suehiro Y; Jiang Y; Wang X; Mitani S; Gong H; Xue D
    Cell Res; 2016 May; 26(5):633-6. PubMed ID: 27055372
    [No Abstract]   [Full Text] [Related]  

  • 7. Lentivirus pre-packed with Cas9 protein for safer gene editing.
    Choi JG; Dang Y; Abraham S; Ma H; Zhang J; Guo H; Cai Y; Mikkelsen JG; Wu H; Shankar P; Manjunath N
    Gene Ther; 2016 Jul; 23(7):627-33. PubMed ID: 27052803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
    Komor AC; Kim YB; Packer MS; Zuris JA; Liu DR
    Nature; 2016 May; 533(7603):420-4. PubMed ID: 27096365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos.
    Kouranova E; Forbes K; Zhao G; Warren J; Bartels A; Wu Y; Cui X
    Hum Gene Ther; 2016 Jun; 27(6):464-75. PubMed ID: 27094534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diversity-generating benefits of a prokaryotic adaptive immune system.
    van Houte S; Ekroth AK; Broniewski JM; Chabas H; Ashby B; Bondy-Denomy J; Gandon S; Boots M; Paterson S; Buckling A; Westra ER
    Nature; 2016 Apr; 532(7599):385-8. PubMed ID: 27074511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Digital PCR-Based Method for Efficient and Highly Specific Screening of Genome Edited Cells.
    Findlay SD; Vincent KM; Berman JR; Postovit LM
    PLoS One; 2016; 11(4):e0153901. PubMed ID: 27089539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases.
    Tsai SQ; Joung JK
    Nat Rev Genet; 2016 May; 17(5):300-12. PubMed ID: 27087594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-on system for the activation of the endogenous human INS gene.
    Giménez CA; Ielpi M; Mutto A; Grosembacher L; Argibay P; Pereyra-Bonnet F
    Gene Ther; 2016 Jun; 23(6):543-7. PubMed ID: 27052801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Protein Depletion in Human Cells by Auxin-Inducible Degron Tagging with Short Homology Donors.
    Natsume T; Kiyomitsu T; Saga Y; Kanemaki MT
    Cell Rep; 2016 Apr; 15(1):210-218. PubMed ID: 27052166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection.
    Estep JA; Sternburg EL; Sanchez GA; Karginov FV
    BMC Mol Biol; 2016 Apr; 17():9. PubMed ID: 27038923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Editing in Human Pluripotent Stem Cells.
    Smith C; Ye Z; Cheng L
    Cold Spring Harb Protoc; 2016 Apr; 2016(4):pdb.top086819. PubMed ID: 27037079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new.
    Sato M; Ohtsuka M; Watanabe S; Gurumurthy CB
    Biol Direct; 2016 Mar; 11(1):16. PubMed ID: 27037013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of Cpf1 in complex with CRISPR RNA.
    Dong D; Ren K; Qiu X; Zheng J; Guo M; Guan X; Liu H; Li N; Zhang B; Yang D; Ma C; Wang S; Wu D; Ma Y; Fan S; Wang J; Gao N; Huang Z
    Nature; 2016 Apr; 532(7600):522-6. PubMed ID: 27096363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering and shaping bacterial diversity through CRISPR.
    Briner AE; Barrangou R
    Curr Opin Microbiol; 2016 Jun; 31():101-108. PubMed ID: 27045713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumer acceptance of food crops developed by genome editing.
    Ishii T; Araki M
    Plant Cell Rep; 2016 Jul; 35(7):1507-18. PubMed ID: 27038939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.